HA

Hidenobu Ando

Director Director DIN 02789552
DIN 02789552 First appointment Aug 2009 Primary industry General Business
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 0 active board seats
Past companies 1 historical roles
Total affiliations 1 Since Aug 2009
Shareholding value Locked Premium profile

About Hidenobu Ando

Data last updated:

Hidenobu Ando has 17 years in corporate governance. Formerly with 1 company, such as Eisai Pharmaceuticals India Private Limited. Engaged in General Business. Contributes to corporate operations.

DIN 02789552
Primary Designation Director
First Appointment 06 Aug 2009
Oldest Company Age Not Provided

Current companies

No current companies available.

Previous companies

CompanyDesignationAppointmentFoundedStatus
Additional Director06 Aug 20092007Active

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Eisai Pharmaceuticals India Private Limited
Premium access

Shareholding and investment profile for Hidenobu Ando

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Hidenobu Ando

Hidenobu Ando has 17 years in corporate governance. Formerly with 1 company, such as Eisai Pharmaceuticals India Private Limited. Engaged in General Business. Contributes to corporate operations.

Hidenobu Ando is associated with 0 companies as a director.

Hidenobu Ando has expertise in General Business.

Hidenobu Ando has 17 years in corporate governance.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available